[Asia Economy Reporter Park Jihwan] Bioneer announced on the 25th that it has decided on a new facility investment related to the expansion of a molecular diagnostic product manufacturing plant worth 5.8 billion KRW.



This corresponds to 18.34% of its equity capital.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing